Utilization of Pap testing among women living with HIV enrolled in primary care in Baltimore, Maryland: A 10-year longitudinal study, 2005–2014

Research output: Contribution to journalArticle

Abstract

Frequent Pap testing is recommended among women living with HIV (WLWH) due to their elevated risk for cervical cancer. However, there are few recent longitudinal evaluations of utilization and determinants of Pap testing among WLWH. Medical and pathology records of WLWH seen at Johns Hopkins Hospital between 2005 and 2014 were assessed using Prentice, Williams, Peterson models. Of 554 WLWH in care for ≥ 18 months, 79% received Pap testing, however only 11% consistently received Pap testing at the recommended interval. Some women (5%) were consistently under-screened (tested at longer intervals) and 21% did not receive any Pap testing at during follow-up. WLWH with decreased likelihood of screening included older women, injection drug users, whites and those who had lived for longer with HIV. In contrast, only women with a prior abnormal Pap result were more likely to receive Pap testing. CD4 cell count and health insurance were not significant determinants. Although many WLWH in care received Pap testing, some WLWH were unscreened or underscreened. Determinants of Pap testing for WLWH include socio-demographic factors and a prior abnormal result; these present potential targets in an urban HIV care setting for closer monitoring and directed interventions to improve utilization among WLWH.

Original languageEnglish (US)
Pages (from-to)52-57
Number of pages6
JournalPapillomavirus Research
Volume6
DOIs
StatePublished - Dec 1 2018

Fingerprint

Baltimore
antineoplaston A10
Longitudinal Studies
Primary Health Care
HIV
Health Insurance
CD4 Lymphocyte Count
Drug Users
Uterine Cervical Neoplasms
Medical Records

Keywords

  • Adherence
  • Cancer screening
  • Cervical cancer
  • HIV
  • Pap testing
  • Prentice, William, Peterson models

ASJC Scopus subject areas

  • Virology
  • Infectious Diseases

Cite this

@article{c7306871e7794a62abeddcfeb427978d,
title = "Utilization of Pap testing among women living with HIV enrolled in primary care in Baltimore, Maryland: A 10-year longitudinal study, 2005–2014",
abstract = "Frequent Pap testing is recommended among women living with HIV (WLWH) due to their elevated risk for cervical cancer. However, there are few recent longitudinal evaluations of utilization and determinants of Pap testing among WLWH. Medical and pathology records of WLWH seen at Johns Hopkins Hospital between 2005 and 2014 were assessed using Prentice, Williams, Peterson models. Of 554 WLWH in care for ≥ 18 months, 79{\%} received Pap testing, however only 11{\%} consistently received Pap testing at the recommended interval. Some women (5{\%}) were consistently under-screened (tested at longer intervals) and 21{\%} did not receive any Pap testing at during follow-up. WLWH with decreased likelihood of screening included older women, injection drug users, whites and those who had lived for longer with HIV. In contrast, only women with a prior abnormal Pap result were more likely to receive Pap testing. CD4 cell count and health insurance were not significant determinants. Although many WLWH in care received Pap testing, some WLWH were unscreened or underscreened. Determinants of Pap testing for WLWH include socio-demographic factors and a prior abnormal result; these present potential targets in an urban HIV care setting for closer monitoring and directed interventions to improve utilization among WLWH.",
keywords = "Adherence, Cancer screening, Cervical cancer, HIV, Pap testing, Prentice, William, Peterson models",
author = "Sally Peprah and {Coleman Fennell}, {Jenell S.} and Anne Rositch and Christopher VandenBussche and Moore, {Richard D} and Gypsyamber D'Souza",
year = "2018",
month = "12",
day = "1",
doi = "10.1016/j.pvr.2018.10.002",
language = "English (US)",
volume = "6",
pages = "52--57",
journal = "Papillomavirus Research",
issn = "2405-8521",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Utilization of Pap testing among women living with HIV enrolled in primary care in Baltimore, Maryland

T2 - A 10-year longitudinal study, 2005–2014

AU - Peprah, Sally

AU - Coleman Fennell, Jenell S.

AU - Rositch, Anne

AU - VandenBussche, Christopher

AU - Moore, Richard D

AU - D'Souza, Gypsyamber

PY - 2018/12/1

Y1 - 2018/12/1

N2 - Frequent Pap testing is recommended among women living with HIV (WLWH) due to their elevated risk for cervical cancer. However, there are few recent longitudinal evaluations of utilization and determinants of Pap testing among WLWH. Medical and pathology records of WLWH seen at Johns Hopkins Hospital between 2005 and 2014 were assessed using Prentice, Williams, Peterson models. Of 554 WLWH in care for ≥ 18 months, 79% received Pap testing, however only 11% consistently received Pap testing at the recommended interval. Some women (5%) were consistently under-screened (tested at longer intervals) and 21% did not receive any Pap testing at during follow-up. WLWH with decreased likelihood of screening included older women, injection drug users, whites and those who had lived for longer with HIV. In contrast, only women with a prior abnormal Pap result were more likely to receive Pap testing. CD4 cell count and health insurance were not significant determinants. Although many WLWH in care received Pap testing, some WLWH were unscreened or underscreened. Determinants of Pap testing for WLWH include socio-demographic factors and a prior abnormal result; these present potential targets in an urban HIV care setting for closer monitoring and directed interventions to improve utilization among WLWH.

AB - Frequent Pap testing is recommended among women living with HIV (WLWH) due to their elevated risk for cervical cancer. However, there are few recent longitudinal evaluations of utilization and determinants of Pap testing among WLWH. Medical and pathology records of WLWH seen at Johns Hopkins Hospital between 2005 and 2014 were assessed using Prentice, Williams, Peterson models. Of 554 WLWH in care for ≥ 18 months, 79% received Pap testing, however only 11% consistently received Pap testing at the recommended interval. Some women (5%) were consistently under-screened (tested at longer intervals) and 21% did not receive any Pap testing at during follow-up. WLWH with decreased likelihood of screening included older women, injection drug users, whites and those who had lived for longer with HIV. In contrast, only women with a prior abnormal Pap result were more likely to receive Pap testing. CD4 cell count and health insurance were not significant determinants. Although many WLWH in care received Pap testing, some WLWH were unscreened or underscreened. Determinants of Pap testing for WLWH include socio-demographic factors and a prior abnormal result; these present potential targets in an urban HIV care setting for closer monitoring and directed interventions to improve utilization among WLWH.

KW - Adherence

KW - Cancer screening

KW - Cervical cancer

KW - HIV

KW - Pap testing

KW - Prentice, William, Peterson models

UR - http://www.scopus.com/inward/record.url?scp=85056215662&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056215662&partnerID=8YFLogxK

U2 - 10.1016/j.pvr.2018.10.002

DO - 10.1016/j.pvr.2018.10.002

M3 - Article

C2 - 30420338

AN - SCOPUS:85056215662

VL - 6

SP - 52

EP - 57

JO - Papillomavirus Research

JF - Papillomavirus Research

SN - 2405-8521

ER -